Further analysis of IPF patient-derived fibroblasts (IPDF) demonstrated that knockdown of CSF3, along with FGF1, IL1β, and CCL11, resulted in changes in fibrosis marker expression. The gene discussed is CSF3; the disease is idiopathic pulmonary fibrosis.